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The	Scandinavian	Society	of	Anaesthesiology	and	Intensive	Care	Medicine	Clinical	
Practice	 Committee	 endorses	 the	 recent	 DASAIM/DSIT guideline for prevention of 
rhabdomyolysis‐induced acute kidney injury.	However,	we	emphasize	the	 low	quality	
of	evidence	with	only	weak	recommendations	for	all	interventions,	highlighting	that	
further	research	is	very	likely	to	have	an	important	impact	on	the	confidence	in	the	
estimate	of	effect	and	is	likely	to	change	the	estimates.
2  |     CHEW Et al
1  | BACKGROUND
Rhabdomyolysis	is	not	uncommon	in	the	critically	ill	and	is	a	conse-
quence	of	a	variety	of	insults	including	crush	injuries,	toxins,	drugs	
and	hypoxia.1	Acute	kidney	injury	(AKI)	 is	a	severe	complication	of	
rhabdomyolysis	 and	 is	most	often	 treated	with	 fluid	 resuscitation,	
along	with	several	supportive	strategies	including	diuretics,	urinary	
alkalinization,	 antioxidants	 and	 renal	 replacement	 therapy.1-4 Best 
practice	recommendations	have	been	difficult	 to	 formulate	due	to	
incomplete	 understanding	 of	 the	 pathogenesis	 behind	 rhabdomy-
olysis	induced	AKI,	lack	of	consensus	definitions	and	lack	of	human	
studies.	 In	 2019,	 the	 Danish	 Society	 of	 Intensive	 Care	 Medicine	
(DSIT)	and	the	Danish	Society	of	Anesthesiology	and	Intensive	Care	
Medicine	 (DASAIM)	 summarized	 the	 available	 evidence	 and	 pro-
vided	 recommendations	 for	 the	 prevention	 of	 rhabdomyolysis‐in-
duced	AKI.5
2  | METHODS
It	was	decided	by	the	Scandinavian	Society	of	Anaesthesiology	and	
Intensive	Care	Medicine	(SSAI)	Clinical	practice	committee	(CPC)	to	
assess	the	DASAIM/DSIT guideline on the prevention of rhabdomyolysis 
induced AKI	for	possible	endorsement.	The	Appraisal	of	Guidelines	
for	REsearch	and	Evaluation	(AGREE)	II	tool,6 was used. Details on 
the	endorsement	process	is	available	elsewhere.7
3  | RESULTS
3.1 | Quality appraisal (AGREE II)
Five	 out	 of	 six	 SSAI	 CPC	members	 completed	 the	 appraisal.	 One	
member	co‐authored	the	guideline	and	was	excluded	from	the	eval-
uation,	as	per	the	SSAI	endorsement	process.6
The	 individual	 domain	 totals	 were:	 Scope	 and	 Purpose	 91%;	
Stakeholder	Involvement	63%;	Rigor	of	Development	79%;	Clarity	of	
Presentation	88%;	Applicability	55%;	Editorial	 Independence	83%;	
Overall	Assessment	77%.
The	 breakdown	 of	 the	 individual	 appraisers	 (de‐identified)	 is	
available	in	the	supplementary	material.
4  | DISCUSSION
There	was	 acceptable	 agreement	 between	 the	 SSAI	CPC	 apprais-
ers	 in	most	 domains.	However,	 there	were	 notable	 limitations	 re-
lated	to	the	applicability	of	the	guidelines	due	to	lack	of	high‐quality	
evidence,	including	data	from	randomized	clinical	trials	in	the	target	
population.	Much	 of	 the	 data	 underpinning	 the	 recommendations	
were	extrapolated	from	other	populations	than	those	suffering	from	
rhabdomyolysis	induced	AKI.	Finally,	there	was	a	lack	of	input	from	
important	stakeholders	such	as	nurses,	dialysis	technicians,	patients,	
caregivers and regulatory bodies.
5  | CONCLUSION
The	SSAI	CPC	endorses	the	DASAIM/DSIT	Clinical	Practice	Guideline	
on	Prevention	of	 rhabdomyolysis‐induced	AKI,	 acknowledging	 the	
poor	quality	of	evidence	underpinning	its	recommendations.
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